Atherosclerosis imaging as a benchmark in the development of novel cardiovasular drugs
Authors:
- Raphael DuivenvoordenRDRaphael Duivenvoorden
- Aart J NederveenANAart J Nederveen
- Eric de GrootEGEric de Groot
- John Jp KasteleinJKJohn Jp Kastelein
- 1 December 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 18 (6) , 613-621
Abstract
Imaging of the arterial wall yields validated surrogate markers that can provide an early indication with regards to efficacy of novel cardiovascular drugs. This paper attempts to address the use of atherosclerosis imaging as a benchmarking tool for a well informed decision whether to proceed to large morbidity and mortality studies in the assessment of a novel therapeutic strategy. Imaging of the artery wall can be used to evaluate individual cardiovascular risk and has additive value over conventional risk scores as it directly addresses the disease process. In controlled clinical trials, vascular imaging has shown that the efficacy of lipid-modifying pharmacotherapy can be evaluated in both high and low-risk populations and that the findings parallel outcomes of clinical studies with similar interventions. Arterial imaging may provide the first glimpse of the efficacy or failure of a novel strategy to combat atherosclerosis. These findings suggest that vascular imaging could be employed to probe whether or not a large morbidity and mortality endpoint study should be the next step in a clinical development program.Keywords
This publication has 71 references indexed in Scilit:
- Surrogate markers for atherosclerotic diseaseCurrent Opinion in Lipidology, 2005
- Carotid Plaques Increase the Risk of Stroke and Subtypes of Cerebral Infarction in Asymptomatic ElderlyCirculation, 2002
- Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older AdultsNew England Journal of Medicine, 1999
- Association of Coronary Heart Disease Incidence with Carotid Arterial Wall Thickness and Major Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993American Journal of Epidemiology, 1997
- Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial InfarctionCirculation, 1997
- George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Surrogate endpoints: A basis for a rational approachEuropean Journal of Clinical Pharmacology, 1992
- Surrogate endpoints in clinical trials: Definition and operational criteriaStatistics in Medicine, 1989
- Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjectsAtherosclerosis, 1988
- Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.Circulation, 1986